Talon Resources Targets Ontario Gold Growth After AIM Move and Eagle Lake Acquisition, CEO Says. Watch here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTransense Regulatory News (TRT)

Share Price Information for Transense (TRT)

Share Price is delayed by 15 minutes
Get Live Data
48.00    0.00 (0.00%)
Bid:
47.00
Ask:
49.00
Spread: 2.00 (4.255%)
Market Cap: £7.31m
TRT Live PriceLast checked at - London Stock Exchange

Intraday Transense Share Chart

Upcoming Investor & Analyst Events

13 May 2024 07:00

RNS Number : 0442O
Transense Technologies PLC
13 May 2024
 

Reach - non-regulatory announcement

 

Transense Technologies plc

 ("Transense" or the "Company")

Upcoming Investor & Analyst Events

Transense Technologies, the provider of specialist sensor technology and measurement systems, announces the following investor and analyst events.

 

Monday 13 May 2024 - MelloMonday

The Company will be attending MelloMonday today, Monday 13 May, starting at 5.00pm, taking place via a Zoom Webinar. Nigel Rogers, Executive Chairman, and Ryan Maughan, Managing Director, will be presenting to webinar participants at 6.00pm, followed by a Q&A. Investors wishing to attend can register here for a free ticket. The recording will be sent out to all registrants within 48 hours of the event.

 

Wednesday 22 May 2024 - Analyst 'get to know Transense' round table

Executive Chairman, Nigel Rogers; Managing Director, Ryan Maughan; and CFO, Melvyn Segal, will be hosting the round table at 4.00pm to present the 'Transense of today', as the Group enters a pivotal point in its journey and recent operational progress brings a refreshed investment case and outlook. Analysts interested in attending should contact Transense@walbrookpr.com.

 

Tuesday 21 & Wednesday 22 May 2024 - Institutional Investor Roadshow

The Transense Directors will be in London holding institutional investor meetings on Tuesday 21 and Wednesday 22 May, hosted by Allenby Capital. 

 

 

For further information please visit www.transense.com or contact:

Transense Technologies plc

Nigel Rogers (Executive Chairman)

Ryan Maughan (Managing Director)

Melvyn Segal (Chief Financial Officer)

Via Walbrook PR

Allenby Capital (Nominated Adviser and Broker)

Jeremy Porter/George Payne (Corporate Finance)

Stefano Aquilino/Tony Quirke (Sales and Corporate Broking)

Tel: +44 (0)20 3328 5656

Walbrook PR

Tom Cooper/Nick Rome/Joesph Walker

Tel: +44 (0)20 7933 8780

Transense@walbrookpr.com

 

Notes to Editors:

Transense is a developer of specialist sensor technology and measurement systems. The Company has two active business divisions:

· Translogik a range of smart, connected tyre inspection and management equipment, used by leading tyre manufacturers, dealers and fleet operators to reduce costs and improve safety; and

 

· SAWsense, developing Surface Acoustic Wave (SAW) sensor technology, to improve performance, reliability and efficiency in focus markets of aerospace, automotive, robotics and industrial machinery.

 

In addition, the Company earns residual royalty income from Bridgestone iTrack (new branding name for iTrack), a tyre condition and performance monitoring system, that was developed by Translogik and subsequently licensed to Bridgestone Corporation for a ten year period in 2020, expiring in 2030.

The Group's strategy is to maximise shareholder value through the delivery of sustained revenue growth from its business divisions by leveraging excellence in innovation and know-how to commercialise technologies through industry partnerships and exposure to global growth markets.

Transense is headquartered in Oxfordshire, UK, and was admitted to trading on AIM, a market operated by the London Stock Exchange (AIM: TRT), in 1999. www.transense.com

For further information please contact transense@walbrookpr.com.

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
NRAQKKBDPBKDQPD
Date   Source Headline
8th Feb 20087:30 amRNSDirector Declaration
8th Feb 20087:00 amRNSBoard and Adviser Change
16th Jan 20082:47 pmRNSHolding(s) in Company
4th Jan 200812:08 pmRNSResult of General Meeting
13th Dec 200710:08 amRNSGrant of Options
10th Dec 200712:56 pmRNSFurther update
7th Dec 20078:00 amRNSAdditional Listing
3rd Dec 200712:18 pmRNSProposed Directorate Changes
21st Nov 20077:30 amRNSRestoration - Transense Techn
21st Nov 20077:30 amRNSFurther Update
20th Nov 200712:14 pmRNSHolding(s) in Company
16th Nov 20073:51 pmRNSResult of EGM
16th Nov 20073:51 pmRNSSuspension - Transense Tech
16th Nov 200710:47 amRNSHolding(s) in Company
15th Nov 20077:03 amRNSGeneral Meeting update
13th Nov 20073:58 pmRNSSchedule 1 - Transense Techno
13th Nov 20077:00 amRNSGeneral Meeting update
2nd Nov 20075:51 pmRNSSchedule 1 - Transense Techno
2nd Nov 200712:53 pmRNSConference Call
26th Oct 20077:30 amRNSConference call
24th Oct 200711:02 amRNSHolding(s) in Company
22nd Oct 20071:30 pmRNSRestoration - Transense Techn
22nd Oct 20071:30 pmRNSAcquisition
17th Oct 20077:00 amRNSHolding(s) in Company
11th Oct 200710:34 amRNSStatement re. Suspension
11th Oct 200710:30 amRNSSuspension - Transense Tech.
28th Sep 20077:03 amRNSInterim Results
25th Sep 20074:25 pmRNSHolding(s) in Company
9th Aug 200711:44 amRNSAIM Rule 26 Compliance
8th Aug 200712:11 pmRNSPatent Agreement
20th Jun 20073:45 pmRNSDirector/PDMR Shareholding
12th Jun 20073:39 pmRNSTotal Voting Rights
25th May 20073:10 pmRNSAGM Statement
24th May 200711:30 amRNSAGM Statement
10th May 20076:04 pmRNSDirector/PDMR Shareholding
19th Apr 20078:00 amRNSDirector/PDMR Shareholding
17th Apr 200710:29 amRNSDirector Resignation
11th Apr 200712:17 pmRNSDirector/PDMR Shareholding
10th Apr 20074:16 pmRNSHolding(s) in Company
30th Mar 20077:03 amRNSFinal Results
14th Mar 20073:49 pmRNSHolding(s) in Company
8th Mar 20072:59 pmRNSHolding(s) in Company
1st Mar 20075:32 pmRNSHolding(s) in Company
26th Feb 20074:14 pmRNSHolding(s) in Company
22nd Feb 20072:20 pmRNSHolding(s) in Company
22nd Feb 20072:15 pmRNSHolding(s) in Company
14th Feb 20074:05 pmRNSHolding(s) in Company
15th Jan 20075:51 pmRNSHolding(s) in Company
10th Jan 20071:45 pmRNSHolding(s) in Company
20th Dec 20067:01 amRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.